Perioperative management of hemostasis

Mrinal Dutia, Eve Rodler, Theodore Wun

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Summary When patients are evaluated for the potential of abnormal bleeding before surgery, the intensity of screening is determined by the hemostatic challenge of the procedure and the likelihood that the patient has an underlying congenital or acquired disorder that would predispose to bleeding. The risk of bleeding associated with the type of surgical procedure ranges from low risk (lymph node biopsies, dental extractions), to moderate risk (laparotomy, thoracotomy, mastectomy), to high risk (neurosurgical, ophthalmic, plastic, cardiopulmonary bypass, prostatic, and surgery to stop bleeding). A screening history should reveal if the patient has experienced any abnormal bleeding or bruising, if there is a history of an acquired medical disorder which could affect hemostasis, if family members have bled abnormally, or if the patient is taking any drugs which could interfere with hemostasis. Physical examination can also provide important information about a patient's surgical bleeding risk. Ecchymoses, petechiae, or purpura may suggest a systemic hemostatic defect. Stigmata of chronic liver disease include hepatomegaly, splenomegaly, jaundice, spider angiomas, palmar erythema, and dilated abdominal veins. The preoperative hemostatic screening recommendations by Rapaport, based on levels of concern, provide a reasonable basis for selecting laboratories for individual patients [1]. Nearly 30 years old, these recommendations are not obsolete.

Original languageEnglish (US)
Title of host publicationMedical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition
PublisherCambridge University Press
Pages223-233
Number of pages11
ISBN (Print)9780511920660, 9781107009165
DOIs
StatePublished - Jan 1 2010

Fingerprint

Hemostasis
Hemorrhage
Hemostatics
Purpura
Ecchymosis
Christianity
Tooth Extraction
Spiders
Hepatomegaly
Splenomegaly
Mastectomy
Thoracotomy
Erythema
Hemangioma
Jaundice
Cardiopulmonary Bypass
Laparotomy
Plastics
Physical Examination
Liver Diseases

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Dutia, M., Rodler, E., & Wun, T. (2010). Perioperative management of hemostasis. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition (pp. 223-233). Cambridge University Press. https://doi.org/10.1017/CBO9780511920660.024

Perioperative management of hemostasis. / Dutia, Mrinal; Rodler, Eve; Wun, Theodore.

Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. p. 223-233.

Research output: Chapter in Book/Report/Conference proceedingChapter

Dutia, M, Rodler, E & Wun, T 2010, Perioperative management of hemostasis. in Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, pp. 223-233. https://doi.org/10.1017/CBO9780511920660.024
Dutia M, Rodler E, Wun T. Perioperative management of hemostasis. In Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press. 2010. p. 223-233 https://doi.org/10.1017/CBO9780511920660.024
Dutia, Mrinal ; Rodler, Eve ; Wun, Theodore. / Perioperative management of hemostasis. Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition. Cambridge University Press, 2010. pp. 223-233
@inbook{b89c3d12a70948ceabe07929991633fe,
title = "Perioperative management of hemostasis",
abstract = "Summary When patients are evaluated for the potential of abnormal bleeding before surgery, the intensity of screening is determined by the hemostatic challenge of the procedure and the likelihood that the patient has an underlying congenital or acquired disorder that would predispose to bleeding. The risk of bleeding associated with the type of surgical procedure ranges from low risk (lymph node biopsies, dental extractions), to moderate risk (laparotomy, thoracotomy, mastectomy), to high risk (neurosurgical, ophthalmic, plastic, cardiopulmonary bypass, prostatic, and surgery to stop bleeding). A screening history should reveal if the patient has experienced any abnormal bleeding or bruising, if there is a history of an acquired medical disorder which could affect hemostasis, if family members have bled abnormally, or if the patient is taking any drugs which could interfere with hemostasis. Physical examination can also provide important information about a patient's surgical bleeding risk. Ecchymoses, petechiae, or purpura may suggest a systemic hemostatic defect. Stigmata of chronic liver disease include hepatomegaly, splenomegaly, jaundice, spider angiomas, palmar erythema, and dilated abdominal veins. The preoperative hemostatic screening recommendations by Rapaport, based on levels of concern, provide a reasonable basis for selecting laboratories for individual patients [1]. Nearly 30 years old, these recommendations are not obsolete.",
author = "Mrinal Dutia and Eve Rodler and Theodore Wun",
year = "2010",
month = "1",
day = "1",
doi = "10.1017/CBO9780511920660.024",
language = "English (US)",
isbn = "9780511920660",
pages = "223--233",
booktitle = "Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition",
publisher = "Cambridge University Press",

}

TY - CHAP

T1 - Perioperative management of hemostasis

AU - Dutia, Mrinal

AU - Rodler, Eve

AU - Wun, Theodore

PY - 2010/1/1

Y1 - 2010/1/1

N2 - Summary When patients are evaluated for the potential of abnormal bleeding before surgery, the intensity of screening is determined by the hemostatic challenge of the procedure and the likelihood that the patient has an underlying congenital or acquired disorder that would predispose to bleeding. The risk of bleeding associated with the type of surgical procedure ranges from low risk (lymph node biopsies, dental extractions), to moderate risk (laparotomy, thoracotomy, mastectomy), to high risk (neurosurgical, ophthalmic, plastic, cardiopulmonary bypass, prostatic, and surgery to stop bleeding). A screening history should reveal if the patient has experienced any abnormal bleeding or bruising, if there is a history of an acquired medical disorder which could affect hemostasis, if family members have bled abnormally, or if the patient is taking any drugs which could interfere with hemostasis. Physical examination can also provide important information about a patient's surgical bleeding risk. Ecchymoses, petechiae, or purpura may suggest a systemic hemostatic defect. Stigmata of chronic liver disease include hepatomegaly, splenomegaly, jaundice, spider angiomas, palmar erythema, and dilated abdominal veins. The preoperative hemostatic screening recommendations by Rapaport, based on levels of concern, provide a reasonable basis for selecting laboratories for individual patients [1]. Nearly 30 years old, these recommendations are not obsolete.

AB - Summary When patients are evaluated for the potential of abnormal bleeding before surgery, the intensity of screening is determined by the hemostatic challenge of the procedure and the likelihood that the patient has an underlying congenital or acquired disorder that would predispose to bleeding. The risk of bleeding associated with the type of surgical procedure ranges from low risk (lymph node biopsies, dental extractions), to moderate risk (laparotomy, thoracotomy, mastectomy), to high risk (neurosurgical, ophthalmic, plastic, cardiopulmonary bypass, prostatic, and surgery to stop bleeding). A screening history should reveal if the patient has experienced any abnormal bleeding or bruising, if there is a history of an acquired medical disorder which could affect hemostasis, if family members have bled abnormally, or if the patient is taking any drugs which could interfere with hemostasis. Physical examination can also provide important information about a patient's surgical bleeding risk. Ecchymoses, petechiae, or purpura may suggest a systemic hemostatic defect. Stigmata of chronic liver disease include hepatomegaly, splenomegaly, jaundice, spider angiomas, palmar erythema, and dilated abdominal veins. The preoperative hemostatic screening recommendations by Rapaport, based on levels of concern, provide a reasonable basis for selecting laboratories for individual patients [1]. Nearly 30 years old, these recommendations are not obsolete.

UR - http://www.scopus.com/inward/record.url?scp=84923449752&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84923449752&partnerID=8YFLogxK

U2 - 10.1017/CBO9780511920660.024

DO - 10.1017/CBO9780511920660.024

M3 - Chapter

AN - SCOPUS:84923449752

SN - 9780511920660

SN - 9781107009165

SP - 223

EP - 233

BT - Medical Management of the Surgical Patient: A Textbook of Perioperative Medicine, Fifth Edition

PB - Cambridge University Press

ER -